Scarica l'app Stockscreener
37.73
0.29%
-0.1471
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$37.88
Aprire:
$37.81
Volume 24 ore:
2.01M
Relative Volume:
0.53
Capitalizzazione di mercato:
$15.91B
Reddito:
$2.26B
Utile/perdita netta:
$1.09B
Rapporto P/E:
16.10
EPS:
2.3431
Flusso di cassa netto:
$2.70B
1 W Prestazione:
+1.35%
1M Prestazione:
+3.85%
6M Prestazione:
+20.10%
1 anno Prestazione:
+37.55%
Intervallo 1D:
$37.57
$38.00
Intervallo di 1 settimana:
$36.37
$38.00
Portata 52W:
$24.05
$38.00
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
37.75 | 15.64B | 2.26B | 1.09B | 2.70B | 2.3431 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.35 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
570.80 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.31 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
678.88 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.83 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-16 | Iniziato | Morgan Stanley | Overweight |
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year HighWhat's Next? - MarketBeat
Royalty Pharma stock hits 52-week high at 37.91 USD - Investing.com
Countdown to Royalty Pharma (RPRX) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
53,119 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by XTX Topco Ltd - MarketBeat
Royalty Pharma (RPRX) Expected to Announce Earnings on Wednesday - MarketBeat
Torray Investment Partners LLC Boosts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Sells 47,438 Shares of Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
What are Royalty Pharma plc company’s key revenue driversIdentify safe investments with exceptional yields - Jammu Links News
What drives Royalty Pharma plc stock priceGet timely alerts on top market movers - Jammu Links News
What analysts say about Royalty Pharma plc stockDiscover breakthrough stocks with expert help - Jammu Links News
Should I hold or sell Royalty Pharma plc stock in 2025Build wealth faster with consistent investment plans - Jammu Links News
TD Asset Management Inc Boosts Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
What markets is GCLWW expanding into Is Royalty Pharma plc stock a good long term investment option - Jammu Links News
What are analysts’ price targets for Royalty Pharma plc in the next 12 monthsUnmatched market gains - Jammu Links News
When is Royalty Pharma plc stock expected to show significant growthBuild a winning investment strategy today - Jammu Links News
What makes Royalty Pharma plc stock price move sharplyAchieve consistent high returns with low risk - Jammu Links News
Is Royalty Pharma plc stock overvalued or undervaluedGet timely alerts on top market movers - Jammu Links News
HB Wealth Management LLC Buys Shares of 12,608 Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
What catalysts could drive Royalty Pharma plc stock higher in 2025Get timely alerts on market opportunities - Jammu Links News
Y Intercept Hong Kong Ltd Acquires New Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
What institutional investors are buying Royalty Pharma plc stockExtraordinary market timing - Jammu Links News
What are the latest earnings results for Royalty Pharma plcMaximize your portfolio’s growth potential - Jammu Links News
Mackenzie Financial Corp Purchases 205,356 Shares of Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Pacific Capital Partners Ltd Invests $5.45 Million in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
What is the risk reward ratio of investing in Royalty Pharma plc stockEarnings Report Alerts With Proven Results - Jammu Links News
Royalty Pharma PLC (NASDAQ:RPRX) Stock Holdings Reduced by Eastern Bank - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Shares Bought by Envestnet Asset Management Inc. - MarketBeat
Ridgewood Investments LLC Trims Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Allianz Asset Management GmbH Has $6.03 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Signal strength of Royalty Pharma plc stock in tech scannersStable Entry High Return Opportunities in Focus - metal.it
Royalty Pharma (RPRX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Royalty Pharma plc stock volume spike explainedScalable Portfolio Growth Suggestions Released - metal.it
Fibonacci Support Holding Strong in Royalty Pharma plcCommunity Verified Stock Suggestions Drive Volume - metal.it
Published on: 2025-07-29 22:21:39 - metal.it
Royalty Pharma PLC (NASDAQ:RPRX) Shares Sold by Mediolanum International Funds Ltd - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year HighWhat's Next? - MarketBeat
Machine Learning Models Forecast Royalty Pharma plc UptickConsistent Income Focused Trade List Analyzed - metal.it
Can Royalty Pharma plc Regain Momentum After BreakdownCommunity Shared Smart Money Signals Show Movement - metal.it
Bollinger Bands Expand on Royalty Pharma plc — Volatility AheadWeekly Chart Analysis With Entry Advice Provided - metal.it
Royalty Pharma stock hits 52-week high at 36.89 USD - Investing.com Australia
Royalty Pharma stock hits 52-week high at 36.89 USD By Investing.com - Investing.com Canada
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.71%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):